Research and Markets has announced the addition of the "Global Migraine Epidemiology and Patient Flow Analysis - 2017" report to their offering.

The results of the Migraine patients study are announced in this new report. The report provides insights into Migraine epidemiology, Migraine diagnosed patients, and Migraine treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Migraine derived from epidemiological analysis, percentage of patients diagnosed with Migraine, and percentage of patients treated with a therapy.

The study helps executives estimate Migraine market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Migraine prevalence, Migraine diagnosis rate, and Migraine treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:

  • Migraine Patient Flow
  • Migraine Prevalence
  • Migraine Diagnosed Patients
  • Migraine Treated Patients

Key Topics Covered:

1. Migraine: Disease Definition

2. Global Migraine Patient Flow

3. Migraine Patient Flow in the US

4. Migraine Patient Flow in Europe

5. Migraine Patient Flow in Germany

6. Migraine Patient Flow in France

7. Migraine Patient Flow in Spain

8. Migraine Patient Flow in Italy

9. Migraine Patient Flow in UK

10. Migraine Patient Flow in Japan

11. Research Methodology

For more information about this report visit http://www.researchandmarkets.com/research/pnh4q9/global_migraine